Avitia Revenue and Competitors
Estimated Revenue & Valuation
- Avitia's estimated annual revenue is currently $2.3M per year.
- Avitia's estimated revenue per employee is $155,000
Employee Data
- Avitia has 15 Employees.
- Avitia grew their employee count by 67% last year.
Avitia's People
Name | Title | Email/Phone |
---|
Avitia Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $25.9M | 221 | 3% | $150.5M | N/A |
#2 | $34.6M | 223 | -56% | N/A | N/A |
#3 | $1.9M | 12 | 20% | N/A | N/A |
#4 | $4M | 26 | -7% | N/A | N/A |
#5 | $67.9M | 438 | 1% | N/A | N/A |
#6 | $10.9M | 70 | 0% | N/A | N/A |
#7 | $10.9M | 70 | 0% | N/A | N/A |
#8 | $27M | 174 | -22% | N/A | N/A |
#9 | $5.1M | 33 | 14% | N/A | N/A |
#10 | $3.9M | 50 | 16% | $65M | N/A |
What Is Avitia?
Cancer doesn’t wait — so we shouldn’t either. \n\nAt Avitia, we’re making sure that clinical labs and oncologists everywhere have the tools they need to diagnose, as well as treat cancer faster. Our AI/ML technology ensures partners have cost-effective NGS-based molecular testing solutions that provide rapid turnaround times. Now, we empower healthcare teams to skip the delays and focus on what matters — personalized patient care.\nFrom pinpointing cancer mutations to streamlining clinical trial access, we’re here to make precision oncology accessible for every community and improve patients’ quality of life.\nLet’s transform cancer care together. \n\nLe cancer n’attend pas, et nous ne devrions pas non plus attendre.\n\nChez Avitia, nous veillons à ce que les laboratoires cliniques et les oncologues du monde entier disposent des outils dont ils ont besoin pour diagnostiquer et traiter le cancer plus rapidement. Notre technologie IA/ML garantit à nos partenaires des solutions de tests moléculaires NGS rentables qui offrent des délais d’exécution rapides. Désormais, nous permettons aux équipes de soins de santé d’éviter les retards et de se concentrer sur ce qui compte : des soins personnalisés aux patients.\nDe l’identification des mutations cancéreuses à la rationalisation de l’accès aux essais cliniques, nous sommes là pour rendre l’oncologie de précision accessible à toutes les communautés et améliorer la qualité de vie des patients.\nTransformons ensemble les soins contre le cancer.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 15 | -25% | N/A |
#2 | $15M | 15 | 7% | N/A |
#3 | $2M | 15 | N/A | N/A |
#4 | $2.3M | 15 | N/A | N/A |
#5 | $1.3M | 15 | -53% | N/A |